Under inflammatory conditions, NF-κB-induced IL-6, secreted from immune cells or tumor cells, can lead to cancer progression and metastasis via the IL-6/signal transducer and activator of transcription 3 (STAT3) signaling pathway [65,66,67]. Here, STAT3 is linked to cancer.